HUBS vs MIRM · P/E 96, rev $1.79B vs rev $336.1M
HubSpot Inc (HUBS) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the HUBS and MIRM stock pages for the full models.
Not investment advice.